Latest & greatest articles for pneumonia

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on pneumonia or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on pneumonia and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for pneumonia

441. Evaluation of home care utility: pneumonia, cerebrovascular disease, urinary tract infections and postsurgical infections

Evaluation of home care utility: pneumonia, cerebrovascular disease, urinary tract infections and postsurgical infections Evaluation of home care utility: pneumonia, cerebrovascular disease, urinary tract infections and postsurgical infections Evaluation of home care utility: pneumonia, cerebrovascular disease, urinary tract infections and postsurgical infections Augustovski F, Pichon Riviere A, Alcaraz A, Bardach A, Ferrante D, Garcia Marti S, Glujovsky D, Lopez A, Regueiro A Record Status (...) This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Augustovski F, Pichon Riviere A, Alcaraz A, Bardach A, Ferrante D, Garcia Marti S, Glujovsky D, Lopez A, Regueiro A. Evaluation of home care utility: pneumonia, cerebrovascular disease, urinary tract infections and postsurgical infections. Buenos Aires: Institute for Clinical Effectiveness and Health Policy (IECS). Informe de

2007 Health Technology Assessment (HTA) Database.

442. Statins and outcomes in patients admitted to hospital with community acquired pneumonia: population based prospective cohort study. Full Text available with Trip Pro

Statins and outcomes in patients admitted to hospital with community acquired pneumonia: population based prospective cohort study. To determine whether statins reduce mortality or need for admission to intensive care in patients admitted to hospital with community acquired pneumonia; and to assess whether previously reported improvements in sepsis related outcomes were a result of the healthy user effect.Population based prospective cohort study.Six hospitals in Capital Health, Edmonton (...) , Alberta, Canada.Adults admitted to hospital with pneumonia and categorised according to use of statins for at least one week before admission and during hospital stay.Composite of in-hospital mortality or admission to an intensive care unit.Of 3415 patients with pneumonia admitted to hospital, 624 (18%) died or were admitted to an intensive care unit. Statin users were less likely to die or be admitted to an intensive care unit than non-users (50/325 (15%) v 574/3090 (19%), odds ratio 0.80, P=0.15

2006 BMJ

443. Review: subglottic secretion drainage reduces ventilator associated pneumonia Full Text available with Trip Pro

Review: subglottic secretion drainage reduces ventilator associated pneumonia Review: subglottic secretion drainage reduces ventilator associated pneumonia | Evidence-Based Nursing We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts OR managers of institutional accounts (...) Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Review: subglottic secretion drainage reduces ventilator associated pneumonia Article Text Treatment Review: subglottic secretion drainage reduces ventilator associated pneumonia Free Bronagh Blackwood , RGN, RNT, PhD, DASE Statistics

2006 Evidence-Based Nursing

444. Chest radiography in children aged 2-59 months diagnosed with non-severe pneumonia as defined by World Health Organization: descriptive multicentre study in Pakistan. Full Text available with Trip Pro

Chest radiography in children aged 2-59 months diagnosed with non-severe pneumonia as defined by World Health Organization: descriptive multicentre study in Pakistan. To evaluate the chest radiographs of children diagnosed with non-severe pneumonia on the basis of the current World Health Organization guidelines (fast breathing alone) for radiological evidence of pneumonia.Descriptive analysis.Outpatient departments of six hospitals in four cities in Pakistan.2000 children with non-severe (...) pneumonia were enrolled; 1932 children were selected for chest radiography.Two consultant radiologists used standardised WHO definitions to evaluate chest radiographs; no clinical information was made available to them. If they disagreed, the radiographs were read by a third radiologist; the final classification was based on agreement between two of the three radiologists.Presence or absence of pneumonia on radiographs.Chest radiographs were reported normal in 1519 children (82%). Radiological evidence

2006 BMJ

445. Review: antibiotics active against atypical pathogens do not improve community acquired pneumonia more than B lactam antibiotics Full Text available with Trip Pro

Review: antibiotics active against atypical pathogens do not improve community acquired pneumonia more than B lactam antibiotics Review: antibiotics active against atypical pathogens do not improve community acquired pneumonia more than β lactam antibiotics | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our (...) . Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Review: antibiotics active against atypical pathogens do not improve community acquired pneumonia more than β lactam antibiotics

2006 Evidence-Based Medicine

446. Antibiotics for treating community acquired pneumonia in people with sickle cell disease. (Abstract)

Antibiotics for treating community acquired pneumonia in people with sickle cell disease. As a consequence of their condition, people with sickle cell disease are at high risk of developing an acute infection of the pulmonary parenchyma called community-acquired pneumonia. Many different bacteria can cause this infection and antibiotic treatment is generally needed to resolve it. There is no standardized approach to antibiotic therapy and treatment is likely to vary from country to country (...) Collaboration methodologies, but no eligible randomized controlled trials were identified.We were unable to find any randomized controlled trials on antibiotic treatment approaches for community-acquired pneumonia in people with sickle cell disease.We were unable to identify randomized controlled trials on efficacy and safety of the antibiotic treatment approaches for people with sickle cell disease suffering from community-acquired pneumonia. Randomized controlled trials are needed to establish the optimum

2006 Cochrane

447. Oral antibiotics versus parenteral antibiotics for severe pneumonia in children. Full Text available with Trip Pro

Oral antibiotics versus parenteral antibiotics for severe pneumonia in children. Acute respiratory infection (ARI) is one of the leading causes of morbidity and mortality in children under five years of age in developing countries. When hospitalisation is required, the usual practice includes administering parenteral antibiotics if a bacterial infection is suspected. This has disadvantages as it causes pain and discomfort to the children, which may lead to treatment refusal or reduced (...) compliance. It is also associated with needle-related complications. In some settings this equipment is in short supply or unavailable necessitating transfer of the child, which increases risks and healthcare costs.To determine the equivalence in effectiveness and safety of oral antibiotic compared to parenteral antibiotic therapies in the treatment of severe pneumonia in children between three months and five years of age.We searched the Cochrane Central Register of Controlled Trials (CENTRAL

2006 Cochrane

448. Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae. (Abstract)

Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae. Five of seven serotypes in the pneumococcal conjugate vaccine, introduced for infants in the United States in 2000, are responsible for most penicillin-resistant infections. We examined the effect of this vaccine on invasive disease caused by resistant strains.We used laboratory-based data from Active Bacterial Core surveillance to measure disease caused by antibiotic-nonsusceptible

2006 NEJM

449. Volume, quality of care, and outcome in pneumonia. (Abstract)

Volume, quality of care, and outcome in pneumonia. The establishment of minimum volume thresholds has been proposed as a means of improving outcomes for patients with various medical and surgical conditions.To determine whether volume is associated with either quality of care or outcome in the treatment of pneumonia.Retrospective cohort study.3243 hospitals participating in the National Pneumonia Quality Improvement Project in 1998 and 1999.13,480 patients with pneumonia cared for by 9741 (...) physicians.The association between the annual pneumonia caseload of physicians and hospitals and adherence to quality-of-care measures and severity-adjusted in-hospital and 30-day mortality rates.Physician volume was unrelated to the timeliness of administration of antibiotics and the obtainment of blood cultures; however, physicians in the highest-volume quartile had lower rates of screening for and administration of influenza (21%, 19%, 20%, and 12% for quartiles 1 through 4, respectively; P < 0.01

2006 Annals of Internal Medicine

450. A randomized trial of diagnostic techniques for ventilator-associated pneumonia. (Abstract)

A randomized trial of diagnostic techniques for ventilator-associated pneumonia. Critically ill patients who require mechanical ventilation are at risk for ventilator-associated pneumonia. Current data are conflicting as to the optimal diagnostic approach in patients who have suspected ventilator-associated pneumonia.In a multicenter trial, we randomly assigned immunocompetent adults who were receiving mechanical ventilation and who had suspected ventilator-associated pneumonia after 4 days (...) of targeted therapy (74.2% and 74.6%, respectively; P=0.90), days alive without antibiotics (10.4+/-7.5 and 10.6+/-7.9, P=0.86), and maximum organ-dysfunction scores (mean [+/-SD], 8.3+/-3.6 and 8.6+/-4.0; P=0.26). The two groups did not differ significantly in the length of stay in the ICU or hospital.Two diagnostic strategies for ventilator-associated pneumonia--bronchoalveolar lavage with quantitative culture of the bronchoalveolar-lavage fluid and endotracheal aspiration with nonquantitative culture

2006 NEJM Controlled trial quality: predicted high

451. Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: a randomised double-blind efficacy study. (Abstract)

Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: a randomised double-blind efficacy study. Acute otitis media is one of the most commonly-diagnosed childhood infections. This study assessed the efficacy of a novel vaccine that contained polysaccharides from 11 different Streptococcus pneumoniae serotypes each conjugated to Haemophilus influenzae-derived protein D

2006 Lancet Controlled trial quality: predicted high

452. Effectiveness of discontinuing antibiotic treatment after three days versus eight days in mild to moderate-severe community acquired pneumonia: randomised, double blind study. Full Text available with Trip Pro

Effectiveness of discontinuing antibiotic treatment after three days versus eight days in mild to moderate-severe community acquired pneumonia: randomised, double blind study. To compare the effectiveness of discontinuing treatment with amoxicillin after three days or eight days in adults admitted to hospital with mild to moderate-severe community acquired pneumonia who substantially improved after an initial three days' treatment.Randomised, double blind, placebo controlled non-inferiority (...) trial.Nine secondary and tertiary care hospitals in the Netherlands.Adults with mild to moderate-severe community acquired pneumonia (pneumonia severity index score < or = 110).Patients who had substantially improved after three days' treatment with intravenous amoxicillin were randomly assigned to oral amoxicillin (n = 63) or placebo (n = 56) three times daily for five days.The primary outcome measure was the clinical success rate at day 10. Secondary outcome measures were the clinical success rate

2006 BMJ Controlled trial quality: predicted high

453. Effectiveness of early switch from intravenous to oral antibiotics in severe community acquired pneumonia: multicentre randomised trial. Full Text available with Trip Pro

Effectiveness of early switch from intravenous to oral antibiotics in severe community acquired pneumonia: multicentre randomised trial. To compare the effectiveness of an early switch to oral antibiotics with the standard 7 day course of intravenous antibiotics in severe community acquired pneumonia.Multicentre randomised controlled trial.Five teaching hospitals and 2 university medical centres in the Netherlands.302 patients in non-intensive care wards with severe community acquired pneumonia (...) . 265 patients fulfilled the study requirements.Three days of treatment with intravenous antibiotics followed, when clinically stable, by oral antibiotics or by 7 days of intravenous antibiotics.Clinical cure and length of hospital stay.302 patients were randomised (mean age 69.5 (standard deviation 14.0), mean pneumonia severity score 112.7 (26.0)). 37 patients were excluded from analysis because of early dropout before day 3, leaving 265 patients for intention to treat analysis. Mortality at day

2006 BMJ Controlled trial quality: predicted high

454. Effect of a clinical pathway to reduce hospitalizations in nursing home residents with pneumonia: a randomized controlled trial. Full Text available with Trip Pro

Effect of a clinical pathway to reduce hospitalizations in nursing home residents with pneumonia: a randomized controlled trial. Nursing home residents with pneumonia are frequently hospitalized. Such transfers may be associated with multiple hazards of hospitalization as well as economic costs.To assess whether using a clinical pathway for on-site treatment of pneumonia and other lower respiratory tract infections in nursing homes could reduce hospital admissions, related complications (...) or functional status. The clinical pathway resulted in an overall cost savings of US 1016 dollars per resident (95% CI, 207 dollars-1824 dollars) treated.Treating residents of nursing homes with pneumonia and other lower respiratory tract infections with a clinical pathway can result in comparable clinical outcomes, while reducing hospitalizations and health care costs.clinicaltrials.gov Identifier: NCT00157612.

2006 JAMA Controlled trial quality: predicted high

455. Prophylactic antibiotics to prevent pneumonia and other complications after measles: community based randomised double blind placebo controlled trial in Guinea-Bissau. Full Text available with Trip Pro

Prophylactic antibiotics to prevent pneumonia and other complications after measles: community based randomised double blind placebo controlled trial in Guinea-Bissau. To investigate whether prophylactic antibiotics can prevent complications of measles.Community based, randomised, double blind, placebo controlled trial.Bandim Health Project study area in Bissau, Guinea-Bissau, west Africa.84 patients with measles during a measles epidemic in Bissau in 1998 (fewer than originally planned owing (...) to interruption by war).Sulfamethoxazole-trimethoprim (co-trimoxazole) or placebo for seven days.Pneumonia and admission to hospital. Also weight change during the first month of infection, diarrhoea, severe fever, oral thrush, stomatitis, conjunctivitis, and otitis media.The median age of the patients with measles was 5.4 (range 0.49-24.8) years. One of 46 participants who received co-trimoxazole developed pneumonia, in contrast to six of 38 participants who received placebo (odds ratio 0.08 (95% confidence

2006 BMJ Controlled trial quality: predicted high

456. Impact of initial discordant treatment with beta-lactam antibiotics on clinical outcomes in adults with pneumococcal pneumonia: a systematic review

Impact of initial discordant treatment with beta-lactam antibiotics on clinical outcomes in adults with pneumococcal pneumonia: a systematic review Impact of initial discordant treatment with beta-lactam antibiotics on clinical outcomes in adults with pneumococcal pneumonia: a systematic review Impact of initial discordant treatment with beta-lactam antibiotics on clinical outcomes in adults with pneumococcal pneumonia: a systematic review Falagas M E, Siempos I I, Bliziotis I A, Panos G Z CRD (...) summary This review concluded that initial discordant beta-lactam antibiotic monotherapy is not associated with a statistically significant increase in mortality, or clinical or bacteriological failure of treatment, compared with concordant monotherapy in adults with pneumococcal pneumonia. The conclusion should be treated with some caution, owing to limitations in the available data and weaknesses in how the review was conducted. Authors' objectives To compare the effectiveness of initial concordant

2006 DARE.

457. Impact of the suctioning system (open vs. closed) on the incidence of ventilation-associated pneumonia: meta-analysis of randomized controlled trials

Impact of the suctioning system (open vs. closed) on the incidence of ventilation-associated pneumonia: meta-analysis of randomized controlled trials Impact of the suctioning system (open vs. closed) on the incidence of ventilation-associated pneumonia: meta-analysis of randomized controlled trials Impact of the suctioning system (open vs. closed) on the incidence of ventilation-associated pneumonia: meta-analysis of randomized controlled trials Vonberg R P, Eckmanns T, Welte T, Gastmeier P CRD (...) summary This review found no significant difference in the incidence of ventilation-associated pneumonia when comparing the use of open and closed suction systems in patients requiring mechanical ventilation. This review was based on only a small, varied sample of patients and is therefore unlikely to be reliable. Authors' objectives To compare the effectiveness of open and closed suction systems on the incidence of ventilation-associated pneumonia (VAP) in patients requiring mechanical ventilation

2006 DARE.

458. Administration of antibiotics via the respiratory tract for the prevention of ICU-acquired pneumonia: a meta-analysis of comparative trials

Administration of antibiotics via the respiratory tract for the prevention of ICU-acquired pneumonia: a meta-analysis of comparative trials Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2006 DARE.

459. Health and economic outcomes of the detection of Klebsiella pneumoniae-produced extended-spectrum beta-lactamase (ESBL) in a hospital with high prevalence of this infection Full Text available with Trip Pro

Health and economic outcomes of the detection of Klebsiella pneumoniae-produced extended-spectrum beta-lactamase (ESBL) in a hospital with high prevalence of this infection Health and economic outcomes of the detection of Klebsiella pneumoniae-produced extended-spectrum beta-lactamase (ESBL) in a hospital with high prevalence of this infection Health and economic outcomes of the detection of Klebsiella pneumoniae-produced extended-spectrum beta-lactamase (ESBL) in a hospital with high (...) , for the detection of extended-spectrum beta-lactamase (ESBL) Klebsiella pneumoniae (K. pneumoniae). Blood cultures for disk diffusion were obtained from patients using the BACTEC 9240 blood culture system (Beckton Dickinson, USA). The E-test was performed using ESBL strips (AB BIODISK). Type of intervention Diagnosis. Economic study type Cost-effectiveness analysis. Study population The study population comprised patients (mainly adults) with positive blood culture results for K. pneumoniae. Patients with false

2006 NHS Economic Evaluation Database.

460. Cost-effectiveness analysis of linezolid compared with vancomycin for the treatment of nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus

Cost-effectiveness analysis of linezolid compared with vancomycin for the treatment of nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus Cost-effectiveness analysis of linezolid compared with vancomycin for the treatment of nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus Cost-effectiveness analysis of linezolid compared with vancomycin for the treatment of nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus Mullins C D (...) , Kuznik A, Shaya F, Obeidat N A, Levine A R, Liu L Z, Wong W Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology The study compared linezolid and vancomycin for the treatment of nosocomial pneumonia (NP) caused by methicillin-resistant

2006 NHS Economic Evaluation Database.